Long-term effects of high intensity resistance and endurance exercise on plasma leptin and ghrelin in overweight individuals:the RESOLVE Study by Tremblay, Angelo et al.
 UWS Academic Portal
Long-term effects of high intensity resistance and endurance exercise on plasma
leptin and ghrelin in overweight individuals
Tremblay, Angelo; Dutheil, Frédéric; Drapeau, Vicky; Metz, Lore; Lesourd, Bruno; Chapier,
Robert; Pereira, Bruno; Verney, Julien; Baker, Julien S.; Vinet, Agnes; Walther, Guillaume;
Obert, Philippe; Courteix, Daniel; Thivel, David
Published in:
Applied Physiology, Nutrition, and Metabolism
DOI:
10.1139/apnm-2019-0019
E-pub ahead of print: 15/03/2019
Document Version
Peer reviewed version
Link to publication on the UWS Academic Portal
Citation for published version (APA):
Tremblay, A., Dutheil, F., Drapeau, V., Metz, L., Lesourd, B., Chapier, R., ... Thivel, D. (2019). Long-term effects
of high intensity resistance and endurance exercise on plasma leptin and ghrelin in overweight individuals: the
RESOLVE Study. Applied Physiology, Nutrition, and Metabolism. https://doi.org/10.1139/apnm-2019-0019
General rights
Copyright and moral rights for the publications made accessible in the UWS Academic Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
Take down policy
If you believe that this document breaches copyright please contact pure@uws.ac.uk providing details, and we will remove access to the
work immediately and investigate your claim.
Download date: 17 Sep 2019
Copyright and reuse of content 
As of 2009, copyright of all articles in NRC Research Press journals remains with the authors. 
Copyright of all articles published prior to 2009 is held by Canadian Science Publishing (operating as 
NRC Research Press) or its licensors. 
 
No part of the NRC Research Press journals may be reproduced, stored, or transmitted in any form 
or by any means, without the written permission, obtainable through RightsLink, except as stated 
below or for those open access journals or articles administered under the terms of a Creative 
Commons license. 
 
Under the Canadian Copyright Act, individuals may download or print single copies of articles for 
personal research or study. Any person may reproduce short excerpts (<100 words) from articles in 
the journals for any purpose that respects the moral rights of authors, provided that the source is 
fully acknowledged. As a courtesy, the consent of the author(s) of such material should be obtained 
directly from the author(s). 
 
Authorization to reproduce items other than for personal research or study, as stated above, may be 
obtained by clicking on the "Reprints & Permissions" link in the Article Tools menu of the article in 
question or under license by Access Copyright. 
 
The NRC Research Press journals also extend certain additional rights to authors. 
For more information: http://www.nrcresearchpress.com/page/librarians/information/terms  
1 
 
Long-term effects of high intensity resistance and endurance exercise on plasma leptin and 1 
ghrelin in overweight individuals: the RESOLVE Study 2 
Angelo Tremblay1,2, Frédéric Dutheil3,4, Vicky Drapeau1,5, Lore Metz6,7, Bruno Lesourd8, Robert 3 
Chapier9, Bruno Pereira10, Julien Verney6,7, Julien S Baker11, Agnes Vinet12, Guillaume Walther12, 4 
Philippe Obert12, Daniel Courteix6,7, David Thivel6,7 5 
 6 
1Institute of Nutrition and Functional Foods (INAF), Université Laval, Quebec City, Canada 7 
2Department of Kinesiology, Université Laval, Quebec City, Canada 8 
3CNRS, LaPSCo, Physiological and Psychosocial Stress, University Hospital of Clermont-Ferrand, 9 
CHU Clermont-Ferrand, Preventive and Occupational Medicine, WittyFit, Université Clermont 10 
Auvergne, Clermont-Ferrand, France. 11 
4Faculty of Health, School of Exercise Science, Australian Catholic University, Melbourne, VIC, 12 
Australia. 13 
5Department of Physical Education, Université Laval, Quebec City, Canada 14 
6Clermont Auvergne University, EA 3533, Laboratory of the Metabolic Adaptations to Exercise 15 
under Physiological and Pathological Conditions (AME2P), Clermont-Ferrand, France. 16 
7CRNH-Auvergne, Clermont-Ferrand, France. 17 
8CHU G. Montpied, F-63000 Clermont-Ferrand, France 18 
9Thermalia Center, F-63140 Châtelguyon, France 19 
10Clermont-Ferrand University hospital, Biostatistics unit (DRCI), Clermont-Ferrand, France 20 
11Institute of Clinical Exercise and Health Sciences, School of Science and Sport, University of the 21 
West of Scotland, Hamilton, Lanarkshire, Scotland, United Kingdom 22 
12Avignon University LAPEC EA4278, F-84000 Avignon, France 23 
 24 
 25 
Running head: Hormonal response to exercise 26 
Corresponding author 27 
Angelo Tremblay, Ph.D. 28 
Department of Kinesiology, PEPS 29 
2300, rue de la Terrasse, Université Laval 30 
Québec, Canada, G1V 0A6 31 
Phone: 418-656-7294 32 
E-mail: angelo.tremblay@kin.ulaval.ca  33 
 34 
Competing interest statement: The authors have no conflict of interest to disclose.  35 
Authors’ implication: all authors significantly took part in the study from its conception to the 36 
analyses of the data and writing of this paper.   37 
2 
 
Abstract 38 
Objective: To evaluate the effects of high intensity resistance and endurance exercise on body 39 
composition and plasma leptin and ghrelin concentrations in overweight individuals.  40 
Methods: 100 participants were randomly assigned to three exercise interventions:  high resistance-41 
low aerobic (Re), low resistance-high aerobic (rE), and low resistance-low aerobic (re). Interventions 42 
began with 3 weeks of residential supervision (Phase1) after which participants had to manage the 43 
physical activity programs individually (Phase2). Body composition and plasma variables were 44 
measured at baseline and after Phase 1 as well as after 3, 6, and 12 months.  45 
Results: Significant decreases in weight and body fat were observed after Phase 1 (p<0.001), and 46 
continued at a lower rate for up to 3 months, and then remained stable for the rest of the protocol. 47 
Once a body weight plateau was reached, body fat loss after the Re and rE conditions exceeded by 48 
1.5-2 kg the fat loss observed in the re condition (p<0.05). Leptin was significantly decreased after 49 
Day 21 and Month 3 (p<0.001) and remained stable for the rest of the study. Ghrelin was significantly 50 
increased after Day 21 and Month 3 (p<0.001) and returned to a level comparable to baseline between 51 
Month 6 and 12 when body weight and fat had reached a plateau.  52 
Conclusions: This study reinforces the idea that an increase in exercise intensity may accentuate 53 
body fat loss before the occurrence of a body weight plateau. Resistance to further fat loss was 54 
accompanied by a decrease in plasma leptin and an increase in plasma ghrelin.  55 
 56 
Key words: obesity, physical activity, energy, appetite, hormones, fat  57 
  58 
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Introduction 59 
Physical activity has been traditionally studied in the etiology and management of obesity because of 60 
its potential to increase energy expenditure. Specifically, research has aimed to determine if there is 61 
a deficit in exercise-induced thermogenesis in obese individuals whereas numerous clinical trials have 62 
tested physical activity as a calorie-burning agent in weight loss interventions. However, we have 63 
also shown that calorie for calorie, high intensity exercise is more susceptible to induce a negative 64 
energy balance than a low to moderate intensity physical activity (27, 29). This effect seems to be 65 
explained by post exercise adaptations such as an increase in resting metabolic rate (32) and an 66 
incomplete compensation in energy intake (14). From a mechanistic standpoint, an increase in beta-67 
adrenergic stimulation was found to be involved in these post exercise effects (25, 32).  Furthermore, 68 
the discovery of hormonal messengers such as leptin and ghrelin has enriched the study of 69 
mechanisms that may underlie the impact of exercise training on energy balance. 70 
Following its discovery in 1994 (34), leptin was shown to promote a negative energy balance via 71 
anorectic and thermogenic effects (11, 18). Leptin was also found to be reduced in exercise-trained 72 
individuals (12) as well as following exercise protocols (13). This is concordant with the study of 73 
Pasman et al. (22) who reported a significant association between the number of hours of exercise 74 
and plasma leptin following a 16-month protocol combining diet and exercise training (22). Leptin 75 
has been found to increase with aging, altogether with increased leptin resistance (Rigamonti et al., 76 
2002). In a recent meta-analysis, Rostas and collaborators found that exercise training favors 77 
decreased leptin concentrations in middle aged and older overweight and obese individuals, resistance 78 
training inducing a more pronounced leptin reduction than aerobic training alone. This suggests a role 79 
for exercise modality on plasma leptin which may be attributable to the different stimulus provided 80 
by resistance and aerobic exercise (Rostas et al., 2017).  81 
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The study of variations in plasma ghrelin is also worth consideration to understand the effects of 82 
exercise training in obese individuals. Ghrelin is an orexigenic hormonal messenger that increases in 83 
blood before eating and immediately decreases after food consumption (6). Accordingly, Cummings 84 
et al. (7) reported an increase in plasma ghrelin in obese individuals subjected to diet-induced weight 85 
loss. In response to exercise training, ghrelin was found to be increased when the intensity of the 86 
exercise stimulus was low to moderate (24). On the other hand, some evidence indicates that high-87 
intensity exercise can reduce plasma ghrelin (2, 30). With age, ghrelin concentration has been found 88 
to decrease as well as the ghrelin signaling pathways (Rigamonti et al., 2002). Markofski et al. found 89 
that a 12-week aerobic + resistance training was able to increase fasting ghrelin concentrations by 90 
47% in 70 years old individuals (Markofski et al., 2014). Interestingly recent results suggest that the 91 
effect of exercise training on ghrelin concentration might depend on the volume of exercise, with 4 92 
months of moderate dose of aerobic exercise favoring reduced ghrelin while it remained unchanged 93 
in response to a low dose training program in old women (Bowyer et al., 2018).     94 
Certain studies have examined the impact of exercise on plasma ghrelin in a context where the 95 
opposite effect of body weight loss was expected to be significant. For instance, Kim et al. (15) 96 
observed that body weight and percent body fat decreased in obese children after a 12-week aerobic 97 
and resistance exercise training while total ghrelin increased by 30.4% and acyl ghrelin did not 98 
change. Martins et al. (19) found that body weight decreased while plasma acyl ghrelin and appetite 99 
increased after 12 weeks of exercise training in sedentary obese women. This is concordant with 100 
results reported by Santosa et al. (23) and Zahorska Markiewicz et al. (33). 101 
Taken together, these observations show that both leptin and ghrelin contribute to the metabolic 102 
regulation underlying the effects of exercise training. In addition, available literature reveals that this 103 
regulation can be modified by time, modalities of exercise practice and variations in body fat. From 104 
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a clinical standpoint, this observation has significant potential implications for obesity management 105 
that deserve further investigations. In the present study, we report relevant data collected in the 106 
RESOLVE Study (9) to document the impact of high-intensity resistance and endurance training 107 
combined with dietary guidelines on plasma leptin and ghrelin in overweight individuals tested at 108 
different time intervals over a 12-month intervention. 109 
Methods 110 
Subjects 111 
A sample of 100 individuals (44 men, 56 women) were recruited to participate in this study via 112 
advertisement. As previously described (9), the following inclusion criteria had to be respected to 113 
permit eligibility: aged between 50 and 70 years, having a diagnosis of metabolic syndrome (METs) 114 
(1), being overweight and sedentary, having maintained a stable body weight and medical treatment 115 
over the last 6 months, to be post-menopausal for women, not to have restricted diet over the previous 116 
year and to have completed a satisfactory VO2max test. Additionally, the participants had to be 117 
exempt from some diseases having the potential to interfere with the metabolic outcome of this study 118 
(9). All subjects gave their written consent to participate in the protocol. 119 
Design  120 
This study is part of the larger RESOLVE project that is a clinical trial designed to investigate the 121 
effects of a lifestyle intervention combining exercise and nutritional diet in individuals with metabolic 122 
syndrome. The full experimental design, population recruitment procedure, eligibility criteria, 123 
measurements as well as compliance and drop-out rates have been previously reported (5, 9, 31). 124 
Briefly, all participants underwent a comprehensive medical screening procedure to ensure their 125 
ability to complete the entire protocol. Eligible subjects were free from clinical signs of heart failure, 126 
coronary artery disease, previous cerebrovascular events, atrial fibrillation and congenital heart 127 
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disease and were not using medication altering body weight or had not been on any restrictive diets 128 
in the previous year. The participants were randomly assigned to one of the three exercise 129 
interventions differing from each other by the relative intensity of resistance (R) and endurance (E) 130 
sessions (with stratification according to age, sex and body mass index), for 3 weeks: i) Condition Re 131 
was a high resistance-moderate endurance exercise whose modalities imposed 10 repetitions at 70% 132 
of 1 maximal repetition and 30% VO2 peak for endurance exercise; ii) Condition rE was performed 133 
at moderate resistance (30%) and high endurance (70%) intensity; iii) Condition re was the reference 134 
condition with both resistance and endurance exercise being performed at 30% maximal reference 135 
values. It is important to note that evaluators were blinded relative to the condition being assigned to 136 
each subject. For the following 12 months, the participants were all requested to maintain the same 137 
training program individually while relying on guidelines and exercise prescription that they had 138 
received in Phase 1.   139 
Anthropometric measurements, body composition (DXA), blood samples, clinical and physical 140 
assessments, daily food intake (3-day food diary) and various health-related questionnaires, were 141 
performed at baseline (D0), after the 3-week intervention (D21), 3, 6 and 12 months after (M3, M6 142 
and M12). The study was approved by the human ethics committee from the University Hospital of 143 
Saint-Etienne, France. The intervention was registered with the American National Institutes of 144 
Health database: No. NCT00917917. 145 
Measurements 146 
Anthropometric measurements and body composition 147 
The participants weight and height was recorded while wearing light clothes and standing bare-148 
footed, using a digital scale and a standard wall-mounted stadiometer respectively. BMI was 149 
calculated as weight (kg) divided by height squared (m²). Waist circumference was measured at 150 
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midpoint between sub-costal and supra-iliac landmarks (21). Fat mass (FM) and fat-free mass (FFM) 151 
were assessed by dual-energy X-ray absorptiometry (DXA) following standardized procedures 152 
(QDR4500A scanner, Hologic, Waltham, MA, USA). 153 
Daily energy intake. 154 
Participants were asked to complete a 3-day dietary recall that was explained and detailed to them by 155 
a member of the investigation team (including 2 week-days and 1 weekend day). The participants 156 
were asked to indicate as precisely as possible all the details regarding the food ingested at each meal 157 
and in-between meals. During their first visit, a specialized dietitian detailed the diary and the 158 
methodology used to fill it in to the participants and the diaries were reviewed afterward with the 159 
participants and the dietitian during a 45 minutes interview. The records have been analyzed by a 160 
trained dietitian using the NutriLog software (Nutrilog SAS, Paris, France).    161 
 162 
Blood samples 163 
Fasting blood samples were drawn between 7.00 and 7.30 a.m. by an experienced nurse, aliquoted 164 
and stored at -80°C until analysis. Basic biological assays were performed in the biochemistry 165 
laboratory of the University Hospital of Clermont-Ferrand, France. Total ghrelin and leptin were 166 
assayed by ELISA using commercial kits (Millipore, Billerica, MA, USA). Sensitivity, intra- and 167 
interassay coefficients of variation were respectively 30 pg/ml, 1.1% and 6.9% for total ghrelin and 168 
0.16 ng/ml, 5.1% and 7.4% for leptin.  169 
Detailed lifestyle intervention  170 
As previously described by Dutheil et al. (9), the protocol for each condition was divided in two 171 
phases: 172 
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Phase 1: This phase elapsed over 3 weeks during which participants stayed in a residential 173 
establishment where their exercise program and food intake were supervised. In each condition, 174 
participants had to perform 15-20 hours of exercise per week that included 90 minutes of daily aerobic 175 
exercise plus four 90 minute weekly resistance exercise sessions. As indicated above, the conditions 176 
differed by the relative intensity of either resistance or endurance exercise. A Polar S810 system was 177 
used to record and store heart rate values. Endurance training included aquagym, cycling and walking 178 
whereas resistance training was based on 8 exercises with free weights and traditional muscular 179 
development equipment. For each exercise, participants had to perform 3 series of 10 repetitions. 180 
Maximal test were realized at baseline to determine the individual acapcities of each participants. 181 
Regarding the resistance intervention, tests were realized for each of the selected exercises in order 182 
to determine the participants 10RM (maximal 10 repetitions). The training intensity increased from 183 
65% to 85% of 10 maximal repetitions for Re, whereas rE and re remained at 30% of 10 maximal 184 
repetitions. Resistance training was done 4 times a week and consisted of 15 min warm-up followed 185 
by height exercises with free weights and traditional muscle building equipment. Exercises were high 186 
pulley machine (lower back), seated row (upper back and trapezius), bench press (chest), chest fly 187 
(chest), squat press (legs), leg extension machine (quadriceps), dumbbell curl (biceps brachial), 188 
triceps pushdown on high pulley (triceps brachial). Each exercise was performed for three sets of 10 189 
repetitions with 1 min rest interval A VO2peak test was also realized by each participants at baseline.  190 
Intensity of the endurance sessions increased gradually from 40 to 75% of VO2max from week 1 to 191 
week 3 for rE, whereas Re and re remained at 30% of VO2max. Throughout the residential program, 192 
participants received both standard and personalized meals prescribed by dietitians. Protein intake 193 
was set at 1.2 g/kg body weight/d and accounted for 15-20% daily energy intake. Lipid and 194 
carbohydrate intake provided 30-35 and 45-55% daily energy intake, respectively. Total daily energy 195 
intake was calculated to promote a 500 kcal daily negative energy balance.  196 
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Phase 2: This phase covered the remaining part of the one-year intervention, i.e. between Day 21 197 
(D21) and the end of Month 12. During this period, participants were requested to maintain the same 198 
training program individually while relying on guidelines and exercise prescription that they had 199 
received in Phase 1. They were met by the exercise coach and the dietitian at months 3, 6, and 12 200 
(M3, M6, M12). As previously described (9), a compliance score was determined on the basis of the 201 
number of food questionnaires returned (score from 0 to 12 i.e. 12 = 100%) and the number of training 202 
sessions undertaken per week (score from 0 to 4, i.e. 4 = 100%). The overall compliance score was 203 
the mean of these two scores (nutrition and physical activity). 204 
Statistical analysis 205 
Statistical analyses were carried out using the statistical software Stata (version 13, StataCorp, 206 
College Station, US). All statistical tests were conducted for a two-sided type I error at 0.05. 207 
Continuous variables were described as mean and standard-deviation, according to statistical 208 
distribution (assumption of normality studied using Shapiro-Wilk test). Repeated correlated data were 209 
analyzed using random-effects models to study fixed effects group (Re, rE, re), time-point evaluation 210 
(baseline, D21, M3, M6, M12) and their interactions taking into account between and within subject 211 
variability (as random-effect). A Sidak’s type I error correction was applied to take into account the 212 
multiple comparisons. Where appropriate, the normality of residuals was studied using Shapiro-Wilk 213 
test. If necessary, a logarithmic transformation was proposed to achieve the normality of dependent 214 
outcome. Furthermore, to determine if the treatment effects on plasma leptin and ghrelin were 215 
independent from variations in BMI, lean and fat mass, multivariable random-effects models were 216 
performed with these variations as covariates. Concerning non-repeated data, the following statistical 217 
tests were performed: Student t-test or Mann-Whitney test if conditions of t-test were not met 218 
(normality studied using Shapiro-Wilk and assumption of homoscedasticity verified by Fisher-219 
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Snedecor test). All enrolled participants were included in the analysis. However, a sensitivity analyses 220 
provided similar results with completers only analysis. 221 
Results 222 
On the initially 100 recruited participants, 91 completed the first phase of the protocol (n=30Re; 223 
n=28rE; n=33re) and 78 completed the entire study, phase 1 and 2 (n=24Re; n=24rE; n=30re). This 224 
Figure 1 presents the flow-chart of the entire study. During phase 2, the mean compliance scores were 225 
54.6 ± 22.1% for Re, 52.7 ± 26.1% for rE, and 52.1 ± 18.1% for re, and did not differ between MetS 226 
groups.   227 
 228 
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 229 
Figure 1. Flow-chart of the entire study. D0: Day 0; D21: Day 21; M3: Month 3; M6: Month 6; M12: Month 12; 230 
Re: Resistance+endurance; rE: resistance+Endurance; re: resistance+endurance. 231 
 232 
Variations in body weight and composition throughout the protocol are presented in Table 1. As 233 
expected, there was a significant decrease in body weight, fat mass and fat-free mass during Phase 1 234 
while physical activity and food intake were closely supervised (p<0.001). From a quantitative 235 
standpoint, the mean fat mass loss during this period was about 3 kg, 3 kg and 2 kg in response to the 236 
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Re, rE and re conditions, respectively. Thus, its energy equivalent (9,300 kcal/kg) means that the 237 
negative energy balance during Phase 1 largely exceeded the 500 kcal daily energy deficit that was 238 
targeted at baseline.  239 
Table 1 also shows that body fat loss continued in Phase 2 up to M3 (p<0.001). Specifically, the fat 240 
loss of 2-3 kg that was achieved over the 70 days elapsing between the end of Phase 1 (D21) and 241 
Month 3 was equivalent to a mean daily energy deficit of about 300 kcal/day. Beyond M3, 242 
fluctuations of fat mass were small and no net noticeable additional fat loss was observed up to the 243 
end of the protocol at M12.  244 
As indicated, fat-free mass also decreased during the protocol (Table 1) (p<0.001). However, it is 245 
noteworthy to emphasize that fat-free mass preservation was almost entirely achieved during the 246 
whole protocol in the Re condition.  247 
  248 
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 249 
Table 1. Body weight and composition at different times during the protocol. 250 
Variables Time 
Condition Mixed Model 
Re rE re Group Time Interaction 
 
 
Body weight 
(kg) 
D0 85.4 ± 12.4 94.0 ± 13.7 89.0 ± 12.7 
<0.05 
Re < rE * 
<0.001 
D0 vs D21 *** 
D0 vs M3 *** 
D0 vs M6 *** 
D0 vs M12 *** 
D21 vs M3 *** 
D21 vs M6 *** 
D21 vs M12** 
0.02 
D21 81.9 ± 11.7 87.1 ± 13.1 85.7 ± 12.1 
M3 79.1 ± 11.3 86.1 ± 12.3 82.6 ± 12.2 
M6 80.4 ± 12.6 86.1 ± 13.6 82.8 ± 12.5 
M12 79.2 ± 11.9 84.9 ± 12.9 82.5 ± 12.7 
BMI (kg/m²) 
D0 32.1 ± 3.9 34.4 ± 4.2 33.9 ± 4.0 
0.04 
Re < rE* 
Re < re 0* 
<0.001 
D0vs D21 *** 
D0vs M3 *** 
D0vs M6 *** 
D0vs M12*** 
D21 vs M3 *** 
D21 vs M6 *** 
D21 vs M12 *** 
M3 vs M12 * 
M6 vs M12 ** 
 
D21 30.8 ± 3.8 33.0 ± 3.9 32.7 ± 3.8  
M3 29.6 ± 3.7 31.5 ± 3.6 31.6 ± 3.9 0.02 
M6 30.2 ± 4.1 31.5 ± 4.0 31.7 ± 3.9  
M12 29.9 ± 3.9 31.3 ± 4.0 31.8 ± 4.0  
 
 
Fat mass (kg) 
D0 27.7 ± 7.6 32.2 ± 7.7 32.3 ± 7.5 
<0.001 
Re < rE ** 
Re < re*** * 
<0.001 
D0vs D21 *** 
D0vs M3 *** 
D0vs M6 *** 
D0vs M12 *** 
D21vs M3 *** 
D21vs M6 *** 
D21vs M12 *** 
M3vs M12* 
M6vs M12 * 
 
D21 24.9 ± 7.1 29.3 ± 7.3 30.1 ± 7.3  
M3 22.1 ± 6.9 26.3 ± 6,8 28.3 ± 6.8 0.03 
M6 23.1 ± 8.3 25.8 ± 7.6 28.0 ± 6.6  
M12 22.7 ± 7.0 26.7 ± 8.1 28.5 ± 7.3  
 
 
FFM (kg) 
D0 57.5 ± 10.8 61.8 ± 11.4 56.5 ± 10.7  <0.001 
D0vs D21 *** 
D0vs M3*** 
D0vs M6 *** 
D0vs M12 *** 
D21vs M3 *** 
D21vs M6*** 
D21vs M12**  
M3vs M12 * 
M6vsM12**  
 
D21 56.9 ± 10.2 60.7 ± 10.8 55.6 ± 10.2   
M3 56.5 ± 10.6 59.5 ± 10.9 54.5 ± 10.8 ns <0.05 
M6 57.1 ± 10.4 60.3 ± 10.7 54.8 ± 10.6   
M12 56.8 ± 11.1 58.1 ± 10.3 54.2 ± 10.8   
Values are means ± SD, D0, D21, M3, M6, and M12 refer to Day 0, Day 21, Month 3, Month 6, and Month 12, respectively; Re: 251 
Resistance+endurance; rE: resistance+Endurance; re: resistance+endurance. *p<0.05; **p<0.01; ***p<0.001.  252 
 253 
Our analysis revealed a significant time effect (p<0.001) for daily energy intake with EI being 254 
significantly higher at D0 compared with the other time points (D21 to M12) without any difference 255 
between the other time points (D21 to M12). Although the analysis also shows a group effect with EI 256 
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being significantly higher in the re group compared with both Re and rE (p<0.01), there was no group 257 
x tome interaction. Variations between time points were not significantly different between groups.  258 
Figure 2 illustrates variations in plasma leptin during the protocol. As expected, there was a 259 
considerable decrease in leptinemia during Phase 1 (p<0.001). This decrease continued between Day 260 
21 and Month 3 (p<0.001). As for fat mass, there was no apparent clinically significant change in 261 
leptinemia between M3 and M12. Variations in plasma ghrelin were also concordant with those of 262 
energy balance up to M3 (Figure 2). Indeed, according to the literature cited above, the negative 263 
energy balance that was imposed at the beginning of the protocol resulted in a significant increase in 264 
plasma ghrelin at D21 and M3 compared to baseline values (p<0.001). The Leptin/ghrelin ration was 265 
found significantly decreased at D21, M3, M6 and M12 compared with D0 in the rE and Re groups 266 
(with no difference between D21, M3, M6 and M12) (p<0.01) but remained unchanged in the re 267 
group.  268 
 269 
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 270 
Figure 2. Plasma leptin (A) and ghrelin (B) concentrations before (D0) and after Phase 1 (D21) and 271 
after 3 (M3), 6 (M6) and 12 (M12) months (Phase 2) for the three treatment conditions:  Resistance 272 
+ endurance (Re), resistance + Endurance (rE), resistance + endurance (re)  273 
Values are means ± SEM; *** p<0.001 compared with D0; * p<0.05 compared with D0. 274 
 275 
However, contrary to other variables documented in this paper which reached a plateau at M3, there 276 
was a substantial decrease in ghrelinemia between M6 and M12 in each condition (Figure 1) to a 277 
level comparable to baseline values.  278 
Discussion 279 
The main objective of this study was to investigate the impact of different modalities of physical 280 
activity practice differing by the intensity of the exercise in combination with diet guidelines stimulus 281 
on body composition and some appetite-related hormones in overweight individuals. A particularity 282 
of the protocol was its implementation during 3 weeks of close in-house exercise and diet supervision 283 
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that were followed by a second phase up to 12 months during which participants had to manage the 284 
program individually. The beginning of the intervention in a controlled residential context promoted 285 
a greater than initially expected energy deficit that was slightly more pronounced in response to high 286 
intensity resistance or endurance exercise. After 3 weeks, once participants had the responsibility to 287 
manage their exercise practice by themselves, daily energy balance and fat loss were reduced up to 3 288 
months from which no further clinically significant morphological changes were observed up to the 289 
end of the program. This apparent inability to further lose body fat after 3 months was accompanied 290 
by substantial opposite changes in leptinemia which decreased, and ghrelinemia which increased in 291 
response to fat loss. However, as further discussed in this section, a considerable decrease in plasma 292 
ghrelin was observed between 6 and 12 months of follow-up when body weight and fat were relatively 293 
stable.  294 
Cross-sectional observations showed that vigorous physical activity is associated with reduced body 295 
fatness, independently of the energy cost of activities (27). This has been corroborated by intervention 296 
studies demonstrating that high intensity exercise accentuates body fat loss while increasing skeletal 297 
muscle oxidative potential (3, 29). These observations are also concordant with results obtained in 298 
standardized laboratory experiments indicating that calorie for calorie, high intensity exercise 299 
influences global energy balance via postexercise adaptations in energy intake, appetite and resting 300 
metabolic rate (14, 16, 32). From a clinical standpoint, these findings have contributed to the 301 
dissemination of guidelines to exercise specialists focussing on the relevance to prescribe vigorous 302 
physical activities as part of fitness programs. However, with respect to the management of excess 303 
weight, these studies have not documented the issue as to "how much additional body fat loss" could 304 
be achieved with high intensity physical activity in weight-reduced overweight individuals before the 305 
occurrence of resistance to further lose body fat. In this regard, the methodology of the present study 306 
contributed to answer this question by comparing the response of body fat over time in overweight 307 
17 
 
people subjected to different modalities of exercise practice. The results showed that when high 308 
intensity exercise was included in the program, be it focussed on resistance or aerobic exercise, mean 309 
body fat loss was accentuated by 1.5 to 2.0 kg before the achievement of a body weight plateau. This 310 
reinforces the relevance to include vigorous physical activity in fitness programs provided that the 311 
exercise stimulus is compatible with the health status of individuals. Our results moreover reinforce 312 
the effect of high intensity exercise since our three groups responded similarly to the interventions in 313 
terms of energy intake.   314 
The findings outlined in the present study also reveal that irrespective to modalities of physical 315 
activity practice, a body weight plateau is ultimately reached after some months of participation in a 316 
program based on exercise and healthy eating, and as indicated above, this happened after 3 months 317 
of intervention in our subjects. Interestingly, this was accompanied by a statistically significant and 318 
quantitatively important decrease in plasma leptin, which is concordant with previously reported 319 
variations in leptin (4). This is in agreement with many studies having demonstrated that a weight-320 
reducing program favors a decrease in plasma leptin, which is related to decreased thermogenesis (8, 321 
28) as well as an increase in hunger sensations (17). This is also concordant with the demonstration 322 
that leptin administration in weight-reduced obese individuals reverses these leptin-related changes 323 
in thermogenesis and appetite (17).   324 
The orexigenic hormone ghrelin has been shown to increase previously with weight loss in the 325 
participants in other studies (7, 15, 19). This change represents a normal response which, together 326 
with the decrease in plasma leptin, promotes body energy preservation in a context of energy 327 
restriction. However, contrary to leptin which remained relatively stable when body weight had 328 
stabilized after 3 months during the experimental protocol, a pronounced decrease in plasma ghrelin 329 
was noted in each condition at the end of the study. Indeed, as depicted in Figure 2, plasma ghrelin 330 
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had then returned to values comparable to baseline levels when body weight and fat remained much 331 
lower than their initial level. This unexpected finding may suggest that long-term physical activity 332 
practice results in hormonal adaptations that facilitate over time the maintenance of reduced body 333 
weight. Obviously, this hypothesis proposing that appetite control in the active person might be 334 
facilitated on the long-term because a decrease in ghrelin deserves experimental confirmation. If 335 
confirmed, this effect on ghrelin could provide a mechanistic explanation of the recognized benefit 336 
of exercise to facilitate body weight/fat maintenance in weight-reduced obese individuals (10, 20, 337 
26). Interestingly, our results also show a reduced Leptin/Ghrelin ration in response to the two 338 
intensive interventions (Re and rE) but not in response to the re one. Although further research is 339 
needed regarding the effect of exercise on this ratio, this is of importance since it might suggest that 340 
intensive exercise might prevent patient for future weight regain compare to ow intensity 341 
interventions. Indeed, as previously showed, a higher fasting L/G ratio has been found associated 342 
with post-weight loss weight regain in overweight and patients with obesity (Crujeiras et al., 2014).       343 
The present study has some strengths and limitations that are worthy of consideration. Among the 344 
strengths, it is relevant to emphasize the duration of the protocol that was sufficiently long to permit 345 
the occurrence of resistance to further lose body fat and to examine its related hormonal changes. The 346 
high volume of training on Phase 1 composes an originality of the intervention made possible by the 347 
residential nature of the program and the continuous presence of professionals. It remains however 348 
hardly transferable in free-living condition as illustrated by the compliance results observed during 349 
phase 2. This self-management of exercise guideline in Phase 2 might also represent a strength of this 350 
study because of a better representativeness of what would happen under free-living conditions. With 351 
respect to hormonal determinations, it is possible that, as described in the introduction of this paper, 352 
the measurement of the active form of ghrelin would have contributed to a more thorough 353 
documentation of the hormonal impact of our exercise intervention. However, it is unlikely that the 354 
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pronounced decrease in ghrelin that was found at the end of the study would not have been also seen 355 
for acyl ghrelin. Another limitation is the use of self-reported dietary recall that might have led to 356 
some underreported results which must be considered when interpreting the present results.    357 
In summary, this study showed that increasing exercise intensity in an intervention combining 358 
physical activity and diet guidelines promotes an accentuation of fat mass loss before body weight 359 
reaches a new plateau in a reduced obese state. This occurrence of resistance exercise to lose fat was 360 
associated with a decrease in plasma leptin and an increase in plasma ghrelin. Unexpectedly, ghrelin 361 
almost returned to baseline values after several months of body weight stabilization. Further research 362 
is needed to determine if this hormonal adaptation represents a long-term benefit of exercise 363 
facilitating appetite control in active weight-reduced obese individuals.  364 
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